Toxicological risks of Chinese herbs
- PMID: 21077025
- DOI: 10.1055/s-0030-1250533
Toxicological risks of Chinese herbs
Abstract
As traditional Chinese medicine (TCM) has become more popular there have been increasing concerns about safety and potential toxicity of the Chinese materia medica (CMM) comprising plants, animal parts and minerals. The potential toxicity of many CMM is well recognised in TCM and to reduce risks use of some herbs is restricted whilst specific processing methods have been developed to modify the activities/toxicity of others. However adverse reactions have been reported, many of these are due misuse or abuse of Chinese medicine. The main problem remains products adulterated with pharmaceuticals for weight loss or erectile dysfunction. But some herbs have narrow therapeutic ranges (e.g., Aconitum species) so toxic effects are frequently reported. Toxic effects from chronic or cumulative dosing are difficult to detect in the traditional setting and recent reports have demonstrated the health problems from Aristolochia species. Despite safety concerns, Chinese medicine appears to be relatively safe with comparatively few reports of adverse reactions compared with overall drug reports. The wealth of information in the Chinese literature needs to be more widely available. As TCM is widely used by patients, improved pharmacovigilance and pharmacoepidemiology can contribute valuable safety information, relevant to clinical use.
© Georg Thieme Verlag KG Stuttgart · New York.
Similar articles
-
Transparently reporting adverse effects of traditional Chinese medicine interventions in randomized controlled trials.Zhong Xi Yi Jie He Xue Bao. 2008 Sep;6(9):881-6. doi: 10.3736/jcim20080901. Zhong Xi Yi Jie He Xue Bao. 2008. PMID: 18782527
-
Quality and safety of Chinese herbal medicines guided by a systems biology perspective.J Ethnopharmacol. 2009 Oct 29;126(1):31-41. doi: 10.1016/j.jep.2009.07.040. Epub 2009 Aug 13. J Ethnopharmacol. 2009. PMID: 19683045 Review.
-
Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective.J Ethnopharmacol. 2012 Apr 10;140(3):519-25. doi: 10.1016/j.jep.2012.01.058. Epub 2012 Feb 21. J Ethnopharmacol. 2012. PMID: 22374080 Review.
-
The rise of traditional Chinese medicine and its materia medica: a comparison of the frequency and safety of materials and species used in Europe and China.J Ethnopharmacol. 2013 Sep 16;149(2):453-62. doi: 10.1016/j.jep.2013.06.050. Epub 2013 Jul 4. J Ethnopharmacol. 2013. PMID: 23832055
-
A unique issue in the standardization of Chinese materia medica: processing.Planta Med. 2010 Dec;76(17):1975-86. doi: 10.1055/s-0030-1250522. Epub 2010 Nov 3. Planta Med. 2010. PMID: 21049396
Cited by
-
Traditional and complementary medicine for promoting healthy ageing in WHO Western Pacific Region: Policy implications from utilization patterns and current evidence.Integr Med Res. 2021 Mar;10(1):100469. doi: 10.1016/j.imr.2020.100469. Epub 2020 Jul 4. Integr Med Res. 2021. PMID: 32874912 Free PMC article. Review.
-
Current regulatory guidelines and resources to support research of dietary supplements in the United States.Crit Rev Food Sci Nutr. 2020;60(2):298-309. doi: 10.1080/10408398.2018.1524364. Epub 2018 Nov 13. Crit Rev Food Sci Nutr. 2020. PMID: 30421981 Free PMC article. Review.
-
Chinese herbal medicine for postinfectious cough: a systematic review of randomized controlled trials.Evid Based Complement Alternat Med. 2013;2013:906765. doi: 10.1155/2013/906765. Epub 2013 Nov 20. Evid Based Complement Alternat Med. 2013. PMID: 24348727 Free PMC article. Review.
-
Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs.J Food Drug Anal. 2018 Apr;26(2S):S45-S60. doi: 10.1016/j.jfda.2018.03.002. Epub 2018 Mar 24. J Food Drug Anal. 2018. PMID: 29703386 Free PMC article. Review.
-
Three-tiered authentication of herbal traditional Chinese medicine ingredients used in women's health provides progressive qualitative and quantitative insight.Front Pharmacol. 2024 Feb 5;15:1353434. doi: 10.3389/fphar.2024.1353434. eCollection 2024. Front Pharmacol. 2024. PMID: 38375033 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
